On the above bi-Weekly chart price action has corrected over 90% since a sell signal in November 2020 @ $13 (not shown). A number of reasons now exist to be bullish , including:
1) A strong buy signal prints (not shown).
2) Regular bullish divergence . Multiple oscillators printing positive divergence with price action over an unspecified period.
3) 2-week Dragonfly DOJI candle.
Is it possible price action falls further? Sure.
Is it probable? No.
Ww
Type: trade
Risk: <=6% of portfolio
Timeframe: Don’t know.
Return: Don’t know
Stop loss: <= 90 cents
1) A strong buy signal prints (not shown).
2) Regular bullish divergence . Multiple oscillators printing positive divergence with price action over an unspecified period.
3) 2-week Dragonfly DOJI candle.
Is it possible price action falls further? Sure.
Is it probable? No.
Ww
Type: trade
Risk: <=6% of portfolio
Timeframe: Don’t know.
Return: Don’t know
Stop loss: <= 90 cents
Trade active
A signal has printed.Note
A very good moment.Note
On supportNote
"Precision BioSciences to Report Fourth Quarter and Fiscal Year 2022 Results on March 9, 2023"The news is already positive.
Note
Stop loss revised to 85 cents.Trade closed: stop reached
Trade active
A very strong bullish divergence has printed on the 2-week.
BTC
bc1q2eckdzh0q8vsd7swcc8et6ze7s99khhxyl7zwy
Weblink: patreon.com/withoutworries
Allow 3-6 months on ideas. Not investment advice. DYOR
bc1q2eckdzh0q8vsd7swcc8et6ze7s99khhxyl7zwy
Weblink: patreon.com/withoutworries
Allow 3-6 months on ideas. Not investment advice. DYOR
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
BTC
bc1q2eckdzh0q8vsd7swcc8et6ze7s99khhxyl7zwy
Weblink: patreon.com/withoutworries
Allow 3-6 months on ideas. Not investment advice. DYOR
bc1q2eckdzh0q8vsd7swcc8et6ze7s99khhxyl7zwy
Weblink: patreon.com/withoutworries
Allow 3-6 months on ideas. Not investment advice. DYOR
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.